- Home
- NEM vs BMY Comparison
NEM vs BMY Comparison
Compare NEM & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEM
- BMY
- Stock Information
- Founded
- NEM 1916
- BMY 1887
- Country
- NEM United States
- BMY United States
- Employees
- NEM N/A
- BMY N/A
- Industry
- NEM Precious Metals
- BMY Biotechnology: Pharmaceutical Preparations
- Sector
- NEM Basic Materials
- BMY Health Care
- Exchange
- NEM Nasdaq
- BMY Nasdaq
- Market Cap
- NEM 93.0B
- BMY 94.0B
- IPO Year
- NEM N/A
- BMY N/A
- Fundamental
- Price
- NEM $87.38
- BMY $44.57
- Analyst Decision
- NEM Buy
- BMY Hold
- Analyst Count
- NEM 9
- BMY 15
- Target Price
- NEM $80.29
- BMY $57.64
- AVG Volume (30 Days)
- NEM 12.6M
- BMY 18.1M
- Earning Date
- NEM 10-23-2025
- BMY 10-30-2025
- Dividend Yield
- NEM 1.15%
- BMY 5.55%
- EPS Growth
- NEM N/A
- BMY N/A
- EPS
- NEM 5.55
- BMY 2.49
- Revenue
- NEM $20,584,000,000.00
- BMY $47,704,000,000.00
- Revenue This Year
- NEM $13.74
- BMY N/A
- Revenue Next Year
- NEM $2.01
- BMY N/A
- P/E Ratio
- NEM $15.65
- BMY $17.96
- Revenue Growth
- NEM 38.38
- BMY 2.57
- 52 Week Low
- NEM $36.86
- BMY $42.96
- 52 Week High
- NEM $89.37
- BMY $63.33
- Technical
- Relative Strength Index (RSI)
- NEM 73.59
- BMY 43.00
- Support Level
- NEM $83.24
- BMY $44.66
- Resistance Level
- NEM $89.37
- BMY $48.58
- Average True Range (ATR)
- NEM 2.39
- BMY 1.19
- MACD
- NEM 0.05
- BMY 0.05
- Stochastic Oscillator
- NEM 83.03
- BMY 25.88
About NEM Newmont Corporation
Newmont is the world's largest gold miner. It bought Goldcorp in 2019, combined its Nevada mines in a joint venture with competitor Barrick later that year, and also purchased competitor Newcrest in November 2023. Its portfolio includes 17 wholly or majority owned mines and interests in two joint ventures in the Americas, Africa, Australia and Papua New Guinea. The company is expected to sell roughly 5.6 million ounces of gold in 2025 from its core mines after selling six higher-cost, smaller mines. Newmont also produces material amounts of copper, silver, zinc, and lead as byproducts. It had about two decades of gold reserves along with significant byproduct reserves at the end of December 2024.
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.